{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:51:30Z","timestamp":1789012290894,"version":"build-2803163510"},"reference-count":73,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.canrad.2025.104720","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T16:30:44Z","timestamp":1757608244000},"page":"104720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Tumour and normal tissue radiosensitivity: 2025 update"],"prefix":"10.1016","volume":"29","author":[{"given":"Ariane","family":"Lapierre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Monge-Cadet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Brengues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Bessi\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Qu\u00e9ro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Mirjolet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Riou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2025.104720_bib0375","series-title":"Chiffres cl\u00e9s de l\u2019observatoire national de la radioth\u00e9rapie entre 2017 et 2021","year":"2023"},{"key":"10.1016\/j.canrad.2025.104720_bib0380","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.canrad.2008.07.009","article-title":"Radiation-induced sequelae: toward an individual profile","volume":"12","author":"Azria","year":"2008","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2025.104720_bib0385","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/09553000701797039","article-title":"DNA double-strand break repair defects in syndromes associated with acute radiation response: at least two different assays to predict intrinsic radiosensitivity?","volume":"84","author":"Joubert","year":"2008","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.canrad.2025.104720_bib0395","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ijrobp.2017.05.044","article-title":"Precision oncology and genomically guided radiation therapy: a report from the American Society for Radiation Oncology\/American Association of Physicists in Medicine\/National Cancer Institute Precision Medicine Conference","volume":"101","author":"Hall","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104720_bib0400","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"key":"10.1016\/j.canrad.2025.104720_bib0405","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2307\/2530862","article-title":"Testing for qualitative interactions between treatment effects and patient subsets","volume":"41","author":"Gail","year":"1985","journal-title":"Biometrics"},{"key":"10.1016\/j.canrad.2025.104720_bib0410","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1200\/JCO.2005.01.112","article-title":"Clinical trial designs for predictive marker validation in cancer treatment trials","volume":"23","author":"Sargent","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2025.104720_bib0415","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M14-0698","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration","volume":"162","author":"Moons","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.canrad.2025.104720_bib0420","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1586\/erm.10.120","article-title":"Integrating biomarkers in clinical trials","volume":"11","author":"Buyse","year":"2011","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.canrad.2025.104720_bib0425","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.3390\/cancers16101942","article-title":"Clinical biomarkers of tumour radiosensitivity and predicting benefit from radiotherapy: a systematic review","volume":"16","author":"Bleaney","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.canrad.2025.104720_bib0430","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/jnci\/dji237","article-title":"Reporting recommendations for tumor marker prognostic studies (REMARK)","volume":"97","author":"McShane","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canrad.2025.104720_bib0435","doi-asserted-by":"crossref","first-page":"7169","DOI":"10.1158\/0008-5472.CAN-05-0656","article-title":"Prediction of radiation sensitivity using a gene expression classifier","volume":"65","author":"Torres-Roca","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.canrad.2025.104720_bib0440","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ijrobp.2009.06.014","article-title":"A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation","volume":"75","author":"Eschrich","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104720_bib0445","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S1470-2045(16)30648-9","article-title":"A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study","volume":"18","author":"Scott","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2025.104720_bib0450","doi-asserted-by":"crossref","first-page":"110287","DOI":"10.1016\/j.radonc.2024.110287","article-title":"Using the genomic adjusted radiation dose (GARD) to personalize the radiation dose in nasopharyngeal cancer","volume":"196","author":"Chiang","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2025.104720_bib0455","article-title":"A clinicogenomic model including GARD predicts outcome for radiation treated patients with HPV+ oropharyngeal squamous cell carcinoma","author":"Ho","year":"2023","journal-title":"MedRxiv Prepr Serv Health Sci"},{"key":"10.1016\/j.canrad.2025.104720_bib0460","doi-asserted-by":"crossref","first-page":"21572","DOI":"10.1038\/s41598-024-72818-w","article-title":"Validation of a genome-based model for adjusting radiotherapy dose (GARD) in patients with locally advanced rectal cancer","volume":"14","author":"Xia","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.canrad.2025.104720_bib0465","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.canrad.2019.07.152","article-title":"Predictive assays for responses of tumors and normal tissues in radiation oncology","volume":"23","author":"Riou","year":"2019","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2025.104720_bib0470","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijrobp.2006.12.005","article-title":"Intact Mre11\/Rad50\/Nbs1 complex predicts good response to radiotherapy in early breast cancer","volume":"68","author":"S\u00f6derlund","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104720_bib0475","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/annonc\/mdu014","article-title":"Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer","volume":"25","author":"Teo","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2025.104720_bib0480","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jnci\/djaa095","article-title":"Pathogenic ATM mutations in cancer and a genetic basis for radiotherapeutic efficacy","volume":"113","author":"Pitter","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canrad.2025.104720_bib0485","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1111\/cas.16168","article-title":"Development and validation of a radiosensitivity model to evaluate radiotherapy benefits in pan-cancer","volume":"115","author":"Yang","year":"2024","journal-title":"Cancer Sci"},{"key":"10.1016\/j.canrad.2025.104720_bib0490","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1158\/1078-0432.CCR-18-0776","article-title":"A five-microRNA signature predicts survival and disease control of patients with head and neck cancer negative for HPV infection","volume":"25","author":"Hess","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.canrad.2025.104720_bib0495","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/cas.13542","article-title":"Significance of tumor-infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer","volume":"109","author":"Matsutani","year":"2018","journal-title":"Cancer Sci"},{"key":"10.1016\/j.canrad.2025.104720_bib0500","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.3390\/curroncol29060342","article-title":"Prognostic and predictive relevance of tumor-infiltrating lymphocytes in squamous cell head-neck cancer patients treated with radical radiotherapy\/chemo-radiotherapy","volume":"29","author":"Koukourakis","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.canrad.2025.104720_bib0505","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","article-title":"International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study","volume":"391","author":"Pag\u00e8s","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2025.104720_bib0510","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1200\/JCO.23.00586","article-title":"International validation of the immunoscore biopsy in patients with rectal cancer managed by a watch-and-wait strategy","volume":"42","author":"El Sissy","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2025.104720_bib0515","doi-asserted-by":"crossref","first-page":"8238","DOI":"10.3390\/ijms21218238","article-title":"Tumour-infiltrating inflammatory cells in early breast cancer: an underrated prognostic and predictive factor?","volume":"21","author":"Schnellhardt","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.canrad.2025.104720_bib0520","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.3390\/cancers15041210","article-title":"Association between tumor mutational burden, stromal CD8+ tumor-infiltrating lymphocytes, and clinical factors in cervical cancers treated with radiotherapy","volume":"15","author":"Ruan","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.canrad.2025.104720_bib0525","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s10147-015-0807-6","article-title":"The pretreatment neutrophil-to-lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer","volume":"20","author":"Mizunuma","year":"2015","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.canrad.2025.104720_bib0530","doi-asserted-by":"crossref","first-page":"e23468","DOI":"10.1002\/jcla.23468","article-title":"Peripheral blood cell count ratios are predictive biomarkers of clinical response and prognosis for non-surgical esophageal squamous cell carcinoma patients treated with radiotherapy","volume":"34","author":"Zhi","year":"2020","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.canrad.2025.104720_bib0535","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4166\/kjg.2022.021","article-title":"Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in hepatocellular carcinoma treated with stereotactic body radiotherapy","volume":"79","author":"Park","year":"2022","journal-title":"Korean J Gastroenterol"},{"key":"10.1016\/j.canrad.2025.104720_bib0540","doi-asserted-by":"crossref","first-page":"19256","DOI":"10.1038\/s41598-023-46476-3","article-title":"Neutrophil to lymphocyte ratio (NTLR) predicts local control and overall survival after stereotactic body radiotherapy (SBRT) in metastatic sarcoma","volume":"13","author":"Somasundaram","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.canrad.2025.104720_bib0545","doi-asserted-by":"crossref","first-page":"e18545","DOI":"10.1097\/MD.0000000000018545","article-title":"The prognostic value of the ratio of neutrophils to lymphocytes before and after intensity modulated radiotherapy for patients with nasopharyngeal carcinoma","volume":"99","author":"Liu","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.canrad.2025.104720_bib0550","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12935-019-0839-5","article-title":"Peripheral memory and na\u00efve T cells in non-small cell lung cancer patients with lung metastases undergoing stereotactic body radiotherapy: predictors of early tumor response","volume":"19","author":"Liu","year":"2019","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.canrad.2025.104720_bib0555","doi-asserted-by":"crossref","first-page":"110390","DOI":"10.1016\/j.radonc.2024.110390","article-title":"Prognostic value of lymphocytes in patients with breast cancer receiving radiotherapy after breast-conserving surgery: a post hoc analysis of a phase III randomized trial","volume":"199","author":"Song","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2025.104720_bib0560","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2018.12.002","article-title":"The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy","volume":"133","author":"Deng","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2025.104720_bib0565","doi-asserted-by":"crossref","first-page":"6719","DOI":"10.1007\/s00432-023-04592-7","article-title":"Mitochondrial metabolism: a predictive biomarker of radiotherapy efficacy and toxicity","volume":"149","author":"Taghizadeh-Hesary","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.canrad.2025.104720_bib0570","doi-asserted-by":"crossref","first-page":"1302074","DOI":"10.3389\/fendo.2023.1302074","article-title":"Exploring a novel seven-gene marker and mitochondrial gene TMEM38A for predicting cervical cancer radiotherapy sensitivity using machine learning algorithms","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.canrad.2025.104720_bib0575","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.semcancer.2023.11.006","article-title":"Tumor hypoxia and radiotherapy: a major driver of resistance even for novel radiotherapy modalities","volume":"98","author":"Beckers","year":"2024","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.canrad.2025.104720_bib0580","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1200\/JCO.23.01308","article-title":"Hypoxia-directed treatment of Human papillomavirus\u2013related oropharyngeal carcinoma","volume":"42","author":"Lee","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2025.104720_bib0585","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/S1470-2045(24)00320-6","article-title":"Adaptive radiotherapy (up to 74Gy) or standard radiotherapy (66Gy) for patients with stage III non-small-cell lung cancer, according to (18F)-FDG-PET tumour residual uptake at 42Gy (RTEP7-IFCT-1402): a multicentre, randomised, controlled phase 2 trial","volume":"25","author":"Vera","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2025.104720_bib0590","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/0140-6736(92)91833-T","article-title":"Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity","volume":"339","author":"Burnet","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2025.104720_bib0595","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/095530098141915","article-title":"Low predictive value of intrinsic fibroblast radiosensitivity for fibrosis development following radiotherapy for breast cancer","volume":"73","author":"Russell","year":"1998","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.canrad.2025.104720_bib0600","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s000660050021","article-title":"Radiation-induced comet-formation in human skin fibroblasts from radiotherapy patients with different normal tissue reactions","volume":"175","author":"Oppitz","year":"1999","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2025.104720_bib0605","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3109\/09553002.2011.582927","article-title":"Biodosimetry using radiation-induced micronuclei in skin fibroblasts","volume":"87","author":"Kaspler","year":"2011","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.canrad.2025.104720_bib0610","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.radonc.2008.01.012","article-title":"Randomized controlled trials in health technology assessment: overkill or overdue?","volume":"86","author":"Bentzen","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2025.104720_bib0615","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.canrad.2023.06.018","article-title":"Revue de morbidit\u00e9 et mortalit\u00e9 en radioth\u00e9rapie\u00a0: proc\u00e9dure, impl\u00e9mentation et perspectives du projet national fran\u00e7ais \u00ab\u00a0Proust\u00a0\u00bb","volume":"27","author":"Belkacemi","year":"2023","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2025.104720_bib0620","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ijrobp.2015.11.013","article-title":"Influence of nucleoshuttling of the ATM protein in the healthy tissues response to radiation therapy: toward a molecular classification of Human radiosensitivity","volume":"94","author":"project investigators","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104720_bib0625","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.canrad.2024.05.002","article-title":"Prediction of radiotherapy toxicity: 20 years of COPERNIC radiosensitivity diagnosis procedure","volume":"28","author":"Sonzogni","year":"2024","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2025.104720_bib0630","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ijrobp.2018.03.047","article-title":"The phosphorylated ATM immunofluorescence assay: a high-performance radiosensitivity assay to predict postradiation therapy overreactions","volume":"101","author":"Vogin","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104720_bib0635","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jtbi.2013.05.020","article-title":"A single formula to describe radiation-induced protein relocalization: towards a mathematical definition of individual radiosensitivity","volume":"333","author":"Bodgi","year":"2013","journal-title":"J Theor Biol"},{"key":"10.1016\/j.canrad.2025.104720_bib0640","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/03008916221078061","article-title":"Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot study","volume":"109","author":"Deneuve","year":"2023","journal-title":"Tumori"},{"key":"10.1016\/j.canrad.2025.104720_bib0645","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0959-8049(97)00373-0","article-title":"No predictive value of the micronucleus assay for patients with severe acute reaction of normal tissue after radiotherapy","volume":"34","author":"Rached","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2025.104720_bib0650","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0360-3016(97)00038-2","article-title":"Rapid assay of intrinsic radiosensitivity based on apoptosis in human CD4 and CD8 T-lymphocytes","volume":"38","author":"Ozsahin","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104720_bib0655","doi-asserted-by":"crossref","first-page":"7426","DOI":"10.1158\/1078-0432.CCR-04-2634","article-title":"CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients","volume":"11","author":"Ozsahin","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.canrad.2025.104720_bib0660","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1470-2045(10)70013-9","article-title":"Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial","volume":"11","author":"Azria","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2025.104720_bib0665","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.ebiom.2015.10.024","article-title":"Radiation-induced CD8 T-lymphocyte apoptosis as a predictor of breast fibrosis after radiotherapy: results of the prospective multicenter French trial","volume":"2","author":"Azria","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.canrad.2025.104720_bib0670","doi-asserted-by":"crossref","first-page":"S2444","DOI":"10.1016\/S0167-8140(24)02014-0","article-title":"1655: Radiation-induced T-lymphocyte apoptosis and prostate radiotherapy: final data of the French trial","volume":"194","author":"Riou","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2025.104720_bib0675","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ebiom.2019.02.031","article-title":"RILA blood biomarker as a predictor of radiation-induced sarcoma in a matched cohort study","volume":"41","author":"Mirjolet","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.canrad.2025.104720_bib0680","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/jnci\/djz075","article-title":"Radiogenomics consortium genome-wide association study meta-analysis of late toxicity after prostate cancer radiotherapy","volume":"112","author":"Kerns","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canrad.2025.104720_bib0685","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00066-024-02237-3","article-title":"Potential single nucleotide polymorphisms markers for radiation dermatitis in head and neck cancer patients: a meta-analysis","volume":"200","author":"Aguiar","year":"2024","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2025.104720_bib0690","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.3390\/cancers14133254","article-title":"An overview on radiation sensitivity in hereditary breast and ovarian cancer syndrome","volume":"14","author":"Gon\u00e7alves","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.canrad.2025.104720_bib0695","doi-asserted-by":"crossref","first-page":"e2898","DOI":"10.1371\/journal.pone.0002898","article-title":"Cytokine plasma levels: reliable predictors for radiation pneumonitis?","volume":"3","author":"R\u00fcbe","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/j.canrad.2025.104720_bib0700","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13014-019-1351-8","article-title":"Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity","volume":"14","author":"Lacombe","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2025.104720_bib0705","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/jrr\/rrae047","article-title":"repair prediction of chronic rare grade\u22653 toxicities induced by radiotherapy using classification algorithms","volume":"65","author":"Muggiolu","year":"2024","journal-title":"J Radiat Res"},{"issue":"6\u20137","key":"10.1016\/j.canrad.2025.104720_bib0710","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.canrad.2024.09.003","article-title":"Artificial intelligence and radiotherapy: evolution or revolution?","volume":"28","author":"Robert","year":"2024","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2025.104720_bib0715","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/09553002.2019.1704908","article-title":"Establishing mechanisms affecting the individual response to ionizing radiation","volume":"96","author":"Averbeck","year":"2020","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.canrad.2025.104720_bib0720","first-page":"1","article-title":"Multi-centre technical evaluation of the radiation-induced lymphocyte apoptosis assay as a predictive test for radiotherapy toxicity","volume":"18","author":"Talbot","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.canrad.2025.104720_bib0725","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fonc.2017.00083","article-title":"Data-based radiation oncology: design of clinical trials in the toxicity biomarkers era","volume":"7","author":"Azria","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2025.104720_bib0730","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2025.104720_bib0735","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1470-2045(16)30102-4","article-title":"Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial","volume":"17","author":"Dearnaley","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2025.104720_bib0740","doi-asserted-by":"crossref","first-page":"103578","DOI":"10.1016\/j.breast.2023.103578","article-title":"Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy","volume":"72","author":"Jaikuna","year":"2023","journal-title":"Breast"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825001362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825001362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T07:54:18Z","timestamp":1765526058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321825001362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":73,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1278321825001362"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104720","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumour and normal tissue radiosensitivity: 2025 update","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104720","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO).","name":"copyright","label":"Copyright"}],"article-number":"104720"}}